Non-invasive prenatal testing (NIPT): MaterniT21+
Our clinic offers 2 types of non-invasive testing: the MaterniT21+ and the MaterniT Genome, which vary depending on the range of syndromes being tested. The test is performed on venous blood.
MaterniT21+ test specifications
The test identifies:
- Down syndrome (trisomy of chromosome 21)
- Edwards syndrome (trisomy of chromosome 18)
- Patau's syndrome (trisomy of chromosome 13)
- Cri du Chat Syndrome - 5p
- DiGeorge syndrome - 22q11
- Prader-Willi syndrome (PWS) and Angelman syndrome (AS) - 15q
- 1p36 deletion syndrome
- Jacobsen syndrome - 11q
- Langer-Giedion syndrome - 8q
- Wolf-Hirschhorn syndrome (WHS) - 4p
- fetal sex
How does the examination work and what is it for?
The NIPT method is very accurate and gentle for both mother and baby. Because some of the genetic information (DNA) of the fetus is released into the blood through the placenta, it is possible to reliably identify chromosomal abnormalities from the blood sample taken.
When is it appropriate to have a blood test?
You can have a NIPT from the 9th week of pregnancy. Ideally, we recommend the 12th week of pregnancy.
Is a non-invasive prenatal test suitable for you?
NIPT is recommended in the case of borderline results from an initial prenatal screening. Also, in case of positive screening for birth defects, when a woman does not consent to invasive chorionic villus or amniotic fluid collection. Non-invasive prenatal testing is also recommended for all pregnant women over 35 years of age.
10 working days
detailed information